S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
NASDAQ:ESRX

Express Scripts (ESRX) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$92.11
$95.87
50-Day Range
$92.33
$92.33
52-Week Range
$66.93
$101.73
Volume
31.61 million shs
Average Volume
6.64 million shs
Market Capitalization
$52.06 billion
P/E Ratio
13.00
Dividend Yield
N/A
Price Target
N/A

ESRX stock logo

About Express Scripts (NASDAQ:ESRX) Stock

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

Receive ESRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Express Scripts and its competitors with MarketBeat's FREE daily newsletter.

ESRX Stock News Headlines

Express Scripts Stages a Small Comeback
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
Express Scripts Inc
Express Scripts, Inc.
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
Express Coupons September 2022
Blue Tower Asset Management Q2 2022 Commentary
U.S. FTC launches inquiry into drug middlemen
Why Express Scripts (ESRX) Is Down Today
See More Headlines

Receive ESRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Express Scripts and its competitors with MarketBeat's FREE daily newsletter.

ESRX Company Calendar

Last Earnings
10/31/2018
Today
5/29/2023

Industry, Sector and Symbol

Industry
Drug Stores & Proprietary Stores
Sub-Industry
Health Care Services
Sector
Medical
Current Symbol
NASDAQ:ESRX
CUSIP
30219G10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$4.52 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100.06 billion
Cash Flow
$10.49 per share
Book Value
$32.00 per share

Miscellaneous

Free Float
N/A
Market Cap
$52.06 billion
Optionable
Optionable
Beta
0.88

Key Executives

  • Mr. Timothy C. WentworthMr. Timothy C. Wentworth (Age 58)
    CEO, Pres & Director
  • Mr. James M. HavelMr. James M. Havel (Age 63)
    Exec. VP & CFO
  • Mr. David A. Queller (Age 49)
    Sr. VP of Sales & Account Management
  • Ms. Christine  HoustonMs. Christine Houston (Age 55)
    Exec. VP of Strategic Integrations
  • Mr. Everett  NevilleMr. Everett Neville (Age 53)
    Exec. VP of Strategy, Supply Chain & Specialty













ESRX Stock - Frequently Asked Questions

How were Express Scripts' earnings last quarter?

Express Scripts Holding (NASDAQ:ESRX) released its earnings results on Wednesday, October, 31st. The company reported $2.43 earnings per share for the quarter, topping analysts' consensus estimates of $2.42 by $0.01. The firm had revenue of $25.56 billion for the quarter, compared to the consensus estimate of $25.11 billion. Express Scripts had a net margin of 4.83% and a trailing twelve-month return on equity of 25.43%. The company's revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.51 EPS.

What other stocks do shareholders of Express Scripts own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Express Scripts investors own include Gilead Sciences (GILD), Bank of America (BAC), Cisco Systems (CSCO), General Electric (GE), Intel (INTC), Walt Disney (DIS), CVS Health (CVS), Boeing (BA), Starbucks (SBUX) and Johnson & Johnson (JNJ).

What is Express Scripts' stock symbol?

Express Scripts trades on the NASDAQ under the ticker symbol "ESRX."

What is Express Scripts' stock price today?

One share of ESRX stock can currently be purchased for approximately $92.33.

How much money does Express Scripts make?

Express Scripts (NASDAQ:ESRX) has a market capitalization of $52.06 billion and generates $100.06 billion in revenue each year. The company earns $4.52 billion in net income (profit) each year or $7.10 on an earnings per share basis.

How can I contact Express Scripts?

Express Scripts' mailing address is ONE EXPRESS WAY, SAINT LOUIS MO, 63121. The official website for the company is www.express-scripts.com. The company can be reached via phone at 314-996-0900 or via email at investor.relations@express-scripts.com.

This page (NASDAQ:ESRX) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -